Susquehanna International Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.94M Buy
257,000
+191,100
+290% +$4.7M ﹤0.01% 3472
2025
Q4
$1.37M Sell
65,900
-82,200
-56% -$1.53M ﹤0.01% 6449
2025
Q3
$2.32M Buy
+148,100
New +$3.06M ﹤0.01% 5467
2024
Q1
Sell
-9,275
Closed -$151K 13558
2023
Q4
$151K Sell
9,275
-1,258
-12% -$21.6K ﹤0.01% 10972
2023
Q3
$195K Buy
+10,533
New +$186K ﹤0.01% 10260
2022
Q1
Sell
-1,042
Closed -$48K 14133
2021
Q4
$48K Buy
+1,042
New +$59.9K ﹤0.01% 12574
2021
Q2
Sell
-1,108
Closed -$169K 13389
2021
Q1
$169K Buy
+1,108
New +$180K ﹤0.01% 11559

Other funds holding TECX

Susquehanna International Group's TECX Position: Q1 2026 in Review

Susquehanna International Group reduced its Tectonic Therapeutic (TECX) stake by 89% in Q1 2026, selling an estimated $3.34M and leaving 16,175 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #9666.

Susquehanna International Group first reported a position in TECX in Q3 2019 and has held it in 16 quarters since. The position peaked at $7.69M in Q4 2024. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Susquehanna International Group held 16,175 shares of Tectonic Therapeutic worth $500K as of Q1 2026.
  • Susquehanna International Group sold 135,538 Tectonic Therapeutic shares in Q1 2026, an estimated $3.34M.
  • Tectonic Therapeutic made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9666 holding.
  • Susquehanna International Group first reported a position in Tectonic Therapeutic in Q3 2019 and has held it in 16 quarters since.
  • Susquehanna International Group's Tectonic Therapeutic position peaked at $7.69M in Q4 2024.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.